의료관광 시장조사

의료 관광은 본국의 의료 비용 증가, 의료 산업의 세계화 및 전 세계적으로 숙련된 의료 인력에 대한 접근성 증가로 인해 전 세계적으로 성장하는 산업입니다. 신흥시장 국가들은 의료 관광객 유치와 헬스케어, 생명공학, 제약 등 첨단 서비스 산업의 수출 증대를 위해 이 산업을 우선적으로 추진하고 있다.

의료 관광은 의료 서비스를 받기 위해 거주 국가 밖으로 여행하는 과정으로 정의됩니다. 많은 사람들이 의료 관광을 더 저렴한 의료 서비스를 받기 위해 부유한 국가에서 개발도상국으로 여행하는 사람들로 인식하지만, 이 과정은 저개발 국가의 사람들이 자국에서 쉽게 제공되지 않는 업무를 수행하기 위해 부유한 국가로 여행하는 반대 상황에도 적용됩니다. .

SIS는 이러한 업무 방식이 가져오는 모든 잠재적 기회와 잠재 고객 및 제공자가 어떻게 치료를 번영시키고 향상시킬 수 있는지 분석합니다.

About the Medical Tourism Market

의료 관광은 전 세계 거의 모든 국가에 존재합니다. 예를 들어, 미국 거주자는 더 저렴한 의료 서비스를 위해 멕시코, 캐나다 또는 중남미 국가로 여행하는 반면, 유럽인은 EU 외부 또는 가격이 더 낮은 국가 간을 여행합니다.

가장 인기 있는 여행지는 쿠바, 그리스, 태국, 한국, 세르비아입니다. 이들 국가의 의사와 전문의는 세계 최고 수준입니다.

사람들이 의료를 위해 다른 나라로 여행하는 가장 일반적인 이유는 다음과 같습니다.

1. 가격 (의료보험을 스스로 감당할 수 없거나 시술 비용이 예산을 훨씬 초과하기 때문에 많은 사람들이 다른 나라로 여행을 하므로 이것이 의료 관광의 주요 이유라고 결론을 내릴 수 있습니다)
2. 서비스의 합법성(낙태 또는 안락사와 같은 일부 의료 서비스는 일부 국가에서 법으로 금지되어 있지만 전부는 아님)
   문화적 차이(많은 이민자들이 종교적 신념 때문에 출신 국가에서 치료를 받기를 원함)
3. 실험 절차에 대한 접근
4. 향상된 진료 품질에 대한 접근

사람들이 다른 나라로 가기로 결정하는 절차에는 불임 치료(예: 대리모, IVF 및 보조 생식 기술), 장기 이식, 성형 수술, 치과 치료 및 실험적인 암 치료 등이 있습니다(단, 이에 국한되지는 않음).

고객 여정 시장 조사 can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical Tourism providers to better serve potential patients.

의료 관광의 가장 흔한 합병증은 다음과 같습니다.

1. 질병 및 감염 위험 – 시술 합병증(상처 또는 기증자 유래 감염)부터 먼 나라로 여행할 경우 감염성 질환까지
2. 항생제에 대한 내성 – 이는 상대적으로 드문 위험이지만 모든 의료 관광객은 이에 대해 알고 있어야 합니다.
3. 의사소통 문제 – 등록된 시설에서만 직원에게 적절한 치료에 필수적인 영어 또는 환자의 모국어에 대한 고급 지식을 제공할 수 있습니다.
4. 항공 여행 – 환자가 수술 후 바로 비행기를 탈 경우 혈전이나 기타 여행 위험이 높으므로 집으로 돌아가기 전에 최소 10~14일을 기다리는 것이 좋습니다.

Medical 관광 시장 조사: How Leading Operators Build Cross-Border Patient Pipelines

Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.

The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.

Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports

Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.

The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.

According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan. This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.

The Five Forces Reshaping Cross-Border Patient Flows

Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.

Payer integration. Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.

Accreditation as table stakes. JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.

Facilitator disintermediation. Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.

Telemedicine pre-screening. Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.

Visa, currency, and geopolitical friction. Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.

What Sophisticated Medical Tourism Market Research Actually Measures

Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.

Source: SIS International Research

The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.

The SIS Approach to Medical Tourism Market Research

SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.

The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.

SIS Corridor Viability Framework

Four dimensions determine whether a corridor merits investment.

• Volume durability. Is the patient flow tied to a structural cost or capacity gap, or to a temporary currency arbitrage?
• Payer concentration. Are the buyers individuals or institutional payers with renewable contracts?
• Clinical defensibility. Does the destination have outcomes data and surgeon depth that withstand a malpractice-conscious payer audit?
• Operational maturity. Are the international patient department, concierge, billing, and follow-up workflows institutionalized or improvised?

Corridors strong on all four, Singapore cardiac, Korea oncology, Turkey dental and orthopedics, sustain investment through currency cycles. Corridors weak on payer concentration or clinical defensibility tend to be margin-thin and reputation-fragile.

Where the Market Goes Next

Three shifts will define the next phase of corridor competition. First, employer-direct contracting will move from pilot programs at large self-funded US employers into mid-market benefits design, expanding addressable demand for centers of excellence in Mexico, Costa Rica, and Colombia. Second, fertility tourism will continue to outgrow other categories as regulatory arbitrage and donor availability concentrate volume in Spain, Greece, the Czech Republic, and parts of Latin America. Third, oncology second opinions delivered remotely will become the primary acquisition channel for high-acuity cross-border cases.

SIS International’s structured expert interviews with overseas medical services agencies indicate that destination preference among high-net-worth outbound patients is driven less by price and more by perceived clinical reputation, language infrastructure, and the agency’s own relationships with named physicians at receiving hospitals. The implication for hospitals is that physician-level brand investment outperforms institutional marketing in this segment.

Medical tourism market research that informs board-level decisions does not stop at market size. It quantifies corridor durability, payer concentration, clinical defensibility, and operational readiness, and it does so with primary evidence from both ends of the patient journey.

SIS 인터내셔널 소개

SIS 국제 정량적, 정성적, 전략 연구를 제공합니다. 우리는 의사결정을 위한 데이터, 도구, 전략, 보고서 및 통찰력을 제공합니다. 또한 인터뷰, 설문 조사, 포커스 그룹, 기타 시장 조사 방법 및 접근 방식을 수행합니다. 문의하기 다음 시장 조사 프로젝트를 위해.